Specialty Billing
Urology Medical Billing Services
Billing for urology practices — dense office procedure schedules, surgical claims with globals, and ancillary lines (imaging, pathology, lithotripsy) each with their own rules.
Urology mixes clinic-based procedures (cystoscopy, biopsies, injections, catheter services) with major surgery and a distinctive ancillary footprint — in-office imaging, pathology on biopsy volume, lithotripsy arrangements — producing claims across nearly every billing category medicine has.
Our urology billing keeps the categories straight: office procedures with same-day E/M handled defensibly, surgical globals calendared, biopsy pathology flows billed correctly between entities, and advanced therapeutics (oncology injections, biologics) run with authorization discipline.
Why Urology Billing Is Complex
Cystoscopy-based procedure families carry bundling relationships payers edit heavily, and office procedures alongside E/M visits invite the same modifier-25 scrutiny dermatology sees. Prostate biopsy pathology involves specimen-count billing that has drawn national audit attention — construction must match the pathology report exactly. Advanced prostate cancer therapeutics bring buy-and-bill economics into the urology office with oncology-grade authorization requirements.
Common Service Categories We Bill
- Office cystoscopy and procedure clinics
- Prostate biopsy programs with pathology
- Stone management: lithotripsy, ureteroscopy
- Urologic oncology surgery and therapeutics
- Urodynamics and incontinence procedures
Common Denial Causes in Urology
- Bundling edits across cystoscopy procedure families
- Specimen-count and pathology construction errors
- Authorization gaps on oncology therapeutics
- Multiple-procedure reductions unposted or unverified
Documentation Risks to Watch
- Specimen counts in claims diverging from pathology reports
- Same-day E/M with procedures thinly differentiated
- Urodynamics component documentation incomplete
Coding Considerations
- Biopsy specimen billing must mirror the pathology report’s specimen handling exactly — a documented federal enforcement focus in past years
- Stone procedures by approach and location carry distinct globals and combination rules
Educational note: Coding and payer information on this page is general educational content, not definitive coding, legal, or reimbursement advice. CPT/ICD-10 rules and payer policies change frequently — verify specifics against current official sources and qualified professionals.
Typical Payer Challenges
- Authorization programs on high-value therapeutics
- Site-of-service differentials between office and ASC procedures
Urology Billing FAQs
How should we bill prostate biopsies with multiple cores?
Directly from the pathology report’s specimen structure — how cores were submitted and examined governs the professional and technical pathology billing, and mismatches between claim construction and the report have been an enforcement target historically. Our workflow reconciles the two documents before submission; this is educational guidance, and current coding policy should be verified per payer.
Do you handle the drug side of advanced prostate cancer treatment?
Yes — office-administered oncology therapeutics in urology follow buy-and-bill mechanics: unit precision, authorization per cycle, and margin reconciliation against acquisition. We run them with the same controls as an oncology infusion suite.
Related Specialties and Texas Locations
Information on this website is provided for general educational purposes only and does not constitute legal, medical, coding, reimbursement, payer, or compliance advice. Coding and payer requirements change frequently; verify current rules with official sources and qualified professionals before acting.
Talk to us about urology billing
Request a free billing assessment and get a clear, no-obligation review of your claims process, denial patterns, and accounts receivable.